Background Prostate cancer (PCa) is the most common male malignancy in the western world. Many men (40%) are diagnosed with localised low or intermediate-risk PCa, which is suitable for active ...

URO-1, Inc. is a life sciences company dedicated to advancing the tools and workflows used in soft tissue biopsy diagnostics.

Molecular profiling of tumors has been shown to improve risk stratification, and it may be useful for prostate cancer active surveillance.

Genitourinary (GU) cancers, including prostate, bladder, renal and testicular malignancies, represent a heterogeneous group of diseases with varying ...

Abstract: Robotic-assisted medical procedures require precise needle tip detection. This is especially important in treatments like prostate brachytherapy. Traditional ultrasound-based manual ...

A new study in Austria has shown that a special ultrasound treatment can effectively control early prostate cancer while helping men keep their quality of life. This method targets only the part of ...

Abstract: There is a need for a reliable, safe, and bedside lung imaging tool that can be used in intensive care units (ICUs). Traditional medical imaging devices such as CT and MRI cannot be easily ...

Prostate cancer burden in 2026 is high, with disproportionate incidence and mortality in Black men and major survival decrements in distant-stage disease, supporting equitable, stage-shifting ...